TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Index Pharmaceuticals AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
98,776
|
0
|
107 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
-88,873
|
-89,245
|
-93,202 |
EBITDA |
-89,536
|
-92,069
|
-93,201 |
Total assets |
277,379
|
286,694
|
333,123 |
Current assets |
277,160
|
286,490
|
332,913 |
Current liabilities |
271,431
|
245,534
|
198,748 |
Equity capital |
5,949
|
41,152
|
134,331 |
- share capital |
6,107
|
5,702
|
5,879 |
Employees (average) |
5
|
6
![]() |
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
2.1%
|
14.4%
|
40.3% |
Turnover per employee |
19,755
|
0
|
18 |
Profit as a percentage of turnover | -90.0% | -87104.7% | |
Return on assets (ROA) |
-32.0%
|
-31.1%
|
-28.0% |
Current ratio |
102.1%
|
116.7%
|
167.5% |
Return on equity (ROE) |
-1493.9%
|
-216.9%
|
-69.4% |
Change turnover |
98,776
|
-104
|
107 |
Change turnover % | -100% | ||
Chg. No. of employees |
-1
|
0
|
1 |
Chg. No. of employees % |
-17%
|
0%
|
20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.